'Major' breakthrough in Covid-19 drug

Pessors Ratko Djukanovic, Stephen Holgate and Donna Davies discovered that people with asthma and chronic lung disease lacked a protein called interferon beta, which helps fight off the common cold. They worked out that patients’ defences against viral infection could be boosted if the missing protein were replaced. The academics created a company, Synairgen, to turn their discoveries into treatments. It floated on the stock market in 2004, but a deal with AstraZeneca to treat viral infections in asthmatics fell through, and the shares collapsed.

Fast-forward a few years to the coronavirus pandemic, however, and suddenly any potential therapeutics for breathing difficulties were in high demand. Richard Marsden, Synairgen’s chief executive, said the company had been deeply involved in a trial using the interferon beta drug to help people with chronic bronchitis or emphysema. “[But] when the coronavirus pandemic emerged, even back in January we realised that we might have an important role to play in defence against this virus,” he said. “So we set about getting a clinical trial set up in February and March in anticipation of the virus coming to the UK, [and] it did. The trial was in place when people started to fill the hospitals up....

https://www.theguardian.com/world/2020/jul/24/major-breakthrough-in-covid-19-drug-makes-uk-professors-millionaires

Popular posts from this blog

The Unreality of Wasseypur: Javed Iqbal

History Archive: Communist Party of India's resolution on Pakistan and National Unity, September 1942

Pakistan's First Law & Labour Minister, Jogendra Nath Mandal's Resignation Letter, October 1950

The Almond Trees by Albert Camus (1940)

Book review: Thirteen Months in China: A Subaltern Indian and the Colonial World

Ben Marks - The Mao Mango Cult of 1968 and the Rise of China's Working Class

Karl Marx: Letter to Abraham Lincoln, President of the United States of America; 1865